BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

621 related articles for article (PubMed ID: 9081786)

  • 21. Isolated limb perfusion with cisplatin and doxorubicin for locally advanced soft tissue sarcoma of an extremity.
    Eroglu A; Kocaoglu H; Demirci S; Akgül H
    Eur J Surg Oncol; 2000 Apr; 26(3):213-21. PubMed ID: 10753532
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Isolated limb perfusion with tumor necrosis factor alpha and melphalan for locally advanced soft tissue sarcoma: three time periods at risk for amputation.
    van Ginkel RJ; Thijssens KM; Pras E; van der Graaf WT; Suurmeijer AJ; Hoekstra HJ
    Ann Surg Oncol; 2007 Apr; 14(4):1499-506. PubMed ID: 17253101
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Complications of combined radiotherapy and isolated limb perfusion with tumor necrosis factor alpha +/- interferon gamma and melphalan in patients with irresectable soft tissue tumors.
    Vrouenraets BC; Keus RB; Nieweg OE; Kroon BB
    J Surg Oncol; 1997 Jun; 65(2):88-94. PubMed ID: 9209519
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Isolated limb perfusion for locally advanced angiosarcoma in extremities: A multi-centre study.
    Huis In 't Veld EA; Grünhagen DJ; Verhoef C; Smith HG; van Akkooi ACJ; Jones R; van Coevorden F; Hayes AJ; van Houdt WJ
    Eur J Cancer; 2017 Nov; 85():114-121. PubMed ID: 28918185
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Isolated limb perfusion with tumor necrosis factor and melphalan for non-resectable soft tissue sarcomas: long-term results on efficacy and limb salvage in a selected group of patients.
    Cherix S; Speiser M; Matter M; Raffoul W; Liénard D; Theumann N; Mouhsine E; Mirimanoff RO; Leyvraz S; Lejeune FJ; Leyvraz PF
    J Surg Oncol; 2008 Sep; 98(3):148-55. PubMed ID: 18668638
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hyperthermic isolated limb perfusion, preoperative radiotherapy, and surgery (PRS) a new limb saving treatment strategy for locally advanced sarcomas.
    Stevenson MG; Seinen JM; Pras E; Brouwers AH; van Ginkel RJ; van Leeuwen BL; Suurmeijer AJH; Been LB; Hoekstra HJ
    J Surg Oncol; 2018 Jun; 117(7):1447-1454. PubMed ID: 29484661
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term outcome of isolated limb perfusion in advanced soft tissue sarcoma of the extremity.
    Olofsson R; Bergh P; Berlin O; Engström K; Gunterberg B; Hansson M; Lindnér P; Mattsson J
    Ann Surg Oncol; 2012 Jun; 19(6):1800-7. PubMed ID: 22219068
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Histological response assessment following neoadjuvant isolated limb perfusion in patients with primary, localised, high-grade soft tissue sarcoma.
    Andreou D; Werner M; Pink D; Traub F; Schuler MK; Gosheger G; Jobke B; Reichardt P; Tunn PU
    Int J Hyperthermia; 2016; 32(2):159-64. PubMed ID: 26670477
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Strategy for multimodal therapy of soft tissue sarcomas of the trunk and extremities].
    Kettelhack C; Tunn U; Schlag PM
    Chirurg; 1998 Apr; 69(4):393-401. PubMed ID: 9612621
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Intraoperative radiotherapy in advanced soft tissue sarcoma of the extremities].
    Schwarzbach M; Willeke F; Eble M; Lehnert T; Ewerbeck V; Wannenmacher M; Herfarth C
    Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():214-7. PubMed ID: 9101835
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Management of soft tissue sarcomas in first isolated local recurrence: a retrospective study of 83 cases].
    Moureau-Zabotto L; Thomas L; Bui BN; Chevreau C; Stockle E; Martel P; Bonneviale P; Marques B; Coindre JM; Kantor G; Matsuda T; Delannes M
    Cancer Radiother; 2004 Oct; 8(5):279-87. PubMed ID: 15561593
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Impact of Perioperative Chemotherapy Timing in Conjunction With Postoperative External-Beam Radiation Therapy on Extremity Soft-Tissue Sarcomas Outcome.
    Mahmoud O; Dosch A; Kwon D; Pitcher JD; Conway S; Benedetto P; Fernandez G; Trent J; Temple HT; Wolfson AH
    Am J Clin Oncol; 2016 Oct; 39(5):528-34. PubMed ID: 24879472
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hyperthermic isolated limb perfusion with tumor necrosis factor-alpha and melphalan in advanced soft-tissue sarcomas: histopathological considerations.
    Issakov J; Merimsky O; Gutman M; Kollender Y; Lev-Chelouche D; Abu-Abid S; Lifschitz-Mercer B; Inbar M; Klausner JM; Meller I
    Ann Surg Oncol; 2000 Mar; 7(2):155-9. PubMed ID: 10761796
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quality of life after hyperthermic isolated limb perfusion for locally advanced extremity soft tissue sarcoma.
    Thijssens KM; Hoekstra-Weebers JE; van Ginkel RJ; Hoekstra HJ
    Ann Surg Oncol; 2006 Jun; 13(6):864-71. PubMed ID: 16614886
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combination regional therapy for extremity sarcoma. A tricenter study.
    Wanebo HJ; Temple WJ; Popp MB; Douvill CE; Yablonski M
    Arch Surg; 1990 Mar; 125(3):355-9. PubMed ID: 2407227
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Repeat isolated limb perfusion with melphalan for recurrent melanoma of the limbs.
    Klop WM; Vrouenraets BC; van Geel BN; Eggermont AM; Klaase JM; Nieweg OE; Kroon BB
    J Am Coll Surg; 1996 Jun; 182(6):467-72. PubMed ID: 8646345
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Soft tissue sarcoma of the upper extremities. Analysis of factors relevant for prognosis in 160 patients].
    Lehnhardt M; Hirche C; Daigeler A; Goertz O; Ring A; Hirsch T; Drücke D; Hauser J; Steinau HU
    Chirurg; 2012 Feb; 83(2):143-52. PubMed ID: 21695557
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma.
    Lienard D; Ewalenko P; Delmotte JJ; Renard N; Lejeune FJ
    J Clin Oncol; 1992 Jan; 10(1):52-60. PubMed ID: 1727926
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hyperthermic isolated perfusion with tumor necrosis factor-alpha and doxorubicin for the treatment of limb-threatening soft tissue sarcoma: the experience of the Italian Society of Integrated Locoregional Treatment in Oncology (SITILO).
    Di Filippo F; Giacomini P; Rossi CR; Santinami M; Garinei R; Anzà M; Deraco M; Botti C; Perri P; Cavaliere F; Di Angelo P; Sofra C; Sperduti I; Pasqualoni R; Di Filippo S; Corrias F; Armenti A; Ferraresi V
    In Vivo; 2009; 23(2):363-7. PubMed ID: 19414428
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modified staging system for extremity soft tissue sarcomas.
    Ramanathan RC; A'Hern R; Fisher C; Thomas JM
    Ann Surg Oncol; 1999; 6(1):57-69. PubMed ID: 10030416
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.